S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Unity Biotechnology (UBX) Earnings Date, Estimates & Call Transcripts

$1.50
-0.02 (-1.31%)
(As of 04/17/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

UBX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UBX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Unity Biotechnology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.57)($0.57)($0.57)
Q2 20241($0.59)($0.59)($0.59)
Q3 20241($0.62)($0.62)($0.62)
Q4 20241($0.64)($0.64)($0.64)
FY 20244($2.42)($2.42)($2.42)

UBX Earnings Date and Information

Unity Biotechnology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Unity Biotechnology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
11/13/2023Q3 2023($0.87)($0.67)+$0.20($0.29)--
8/8/2023Q2 2023($0.83)($0.85)($0.02)($0.85)--
5/9/2023Q1 2023($1.10)($0.76)+$0.34($0.76)--
3/15/2023Q4 2022($1.15)($1.00)+$0.15($1.00)--
11/8/2022Q3 2022($0.99)($1.36)($0.37)($1.36)--
8/12/2022Q2 2022($2.80)($1.90)+$0.90($0.19)-$0.24 million
5/10/2022Q1 2022($2.60)($2.80)($0.20)($0.28)--    
3/15/2022Q4 2021($3.10)($1.80)+$1.30($0.18)-$4.78 million
11/10/2021Q3 2021($3.60)($3.00)+$0.60($0.30)--
8/9/2021Q2 2021($3.20)($3.20)-($0.32)--
5/12/2021Q1 2021($3.80)($2.90)+$0.90($0.29)--

Unity Biotechnology Earnings - Frequently Asked Questions

When is Unity Biotechnology's earnings date?

Unity Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on UBX's earnings history.

How much revenue does Unity Biotechnology generate each year?

Unity Biotechnology (NASDAQ:UBX) has a recorded annual revenue of $240,000.00.

How much profit does Unity Biotechnology generate each year?

Unity Biotechnology (NASDAQ:UBX) has a recorded net income of -$59.93 million. UBX has generated -$2.94 earnings per share over the last four quarters.

What is Unity Biotechnology's EPS forecast for next year?

Unity Biotechnology's earnings are expected to grow from ($2.66) per share to ($1.98) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:UBX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners